Canada markets close in 2 hours 3 minutes

Greenwich LifeSciences, Inc. (GLSI)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
19.71-0.29 (-1.45%)
As of 01:38PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous Close20.00
Open20.21
Bid19.58 x 100
Ask20.52 x 100
Day's Range19.71 - 20.55
52 Week Range7.58 - 21.44
Volume21,139
Avg. Volume47,904
Market Cap253.238M
Beta (5Y Monthly)3.11
PE Ratio (TTM)N/A
EPS (TTM)-0.70
Earnings DateMar 31, 2024 - Apr 04, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est36.00
  • GlobeNewswire

    Greenwich LifeSciences Extends Lock-up of Directors and Officers to June 30, 2025

    STAFFORD, Texas, March 13, 2024 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences, today announced that its Board of Directors has extended the lock-up of the shares owned by the Company's directors, officers, and existing pre-IPO investors to June 30, 2025 which is approximately 57 mont

  • GlobeNewswire

    Greenwich LifeSciences Partners with GEICAM in Spain & Conducts First Site Initiation Visits in Europe

    STAFFORD, Texas, March 12, 2024 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences, today announced the initiation of the first clinical sites in Europe in collaboration with GEICAM in Spain. The Company has partnered with GEICAM, the largest academic breast cancer research network in Spa

  • GuruFocus.com

    Greenwich LifeSciences Inc (GLSI) CEO and CFO, 10% Owner Snehal Patel Acquires Additional Shares

    Greenwich LifeSciences Inc (NASDAQ:GLSI) has reported an insider purchase by CEO and CFO, 10% Owner Snehal Patel, according to a recent SEC filing.